Get the Stockscreener App
0.7105
41.03%
-0.4595
Brainstorm Cell Therapeutics Inc stock is traded at $0.7105, with a volume of 5,719.
It is down -41.03% in the last 24 hours and down -43.90% over the past month.
BRAINSTORM CELL THERAPUTC
See More
Previous Close:
$1.17
Open:
$0.75
24h Volume:
5,719
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-16.63M
P/E Ratio:
-1.6523
EPS:
-0.43
Net Cash Flow:
$-21.84M
1W Performance:
-41.03%
1M Performance:
-43.90%
6M Performance:
-68.49%
1Y Performance:
-87.10%
1-Day Range:
$0.7105
$0.7997
1-Week Range:
$0.7105
$0.7997
52-Week Range:
$0.7105
$0.7997
Brainstorm Cell Therapeutics Inc Stock (BCLI) Company Profile
Name
Brainstorm Cell Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare BCLI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCLI
Brainstorm Cell Therapeutics Inc
|
0.7105 | 0 | 0 | -16.63M | -21.84M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.37 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
468.58 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.20 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
763.52 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.67 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-21 | Upgrade | Maxim Group | Hold → Buy |
| Nov-17-20 | Downgrade | Maxim Group | Buy → Hold |
| Dec-19-16 | Reiterated | Maxim Group | Buy |
| Dec-22-15 | Reiterated | Maxim Group | Buy |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Latest News
Is Brainstorm Cell Therapeutics Inc. in a long term uptrendInsider Selling & Risk Controlled Stock Alerts - Lancaster City Council
Why Brainstorm Cell Therapeutics Inc. is moving todayWeekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
What technical models suggest about Brainstorm Cell Therapeutics Inc.’s comebackJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - Newser
Can Brainstorm Cell Therapeutics Inc. deliver alpha2025 Key Lessons & Daily Stock Momentum Reports - خودرو بانک
What is the dividend yield of Brainstorm Cell Therapeutics Inc.Market Growth Summary & Weekly Momentum Picks - خودرو بانک
Does Brainstorm Cell Therapeutics Inc. have declining or rising EPSJuly 2025 Sentiment & Precise Swing Trade Entry Alerts - خودرو بانک
Can Brainstorm Cell Therapeutics Inc. scale operations efficientlyWeekly Profit Recap & Capital Efficient Trading Techniques - خودرو بانک
Can machine learning forecast Brainstorm Cell Therapeutics Inc. recoveryInsider Selling & AI Powered Trade Plan Recommendations - Newser
Regression analysis insights on Brainstorm Cell Therapeutics Inc. performanceJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
Brainstorm Cell Therapeutics Inc. stock daily chart insightsEarnings Risk Summary & Low Drawdown Trading Strategies - Newser
Tools to monitor Brainstorm Cell Therapeutics Inc. recovery probabilityWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - Newser
Is Brainstorm Cell Therapeutics Inc. trading at a discountWeekly Investment Recap & Reliable Price Breakout Alerts - خودرو بانک
Will Brainstorm Cell Therapeutics Inc. stock recover after recent dropJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - Newser
Will Brainstorm Cell Therapeutics Inc. continue its uptrendMarket Activity Report & Free Technical Confirmation Trade Alerts - Newser
Published on: 2025-09-04 06:13:26 - Newser
Heatmap analysis for Brainstorm Cell Therapeutics Inc. and competitorsTake Profit & Weekly High Potential Alerts - Newser
Chart overlay techniques for tracking Brainstorm Cell Therapeutics Inc.2025 Retail Activity & Community Verified Swing Trade Signals - Newser
Is Brainstorm Cell Therapeutics Inc. stock poised for growthM&A Rumor & Safe Capital Growth Stock Tips - Newser
Can momentum traders help lift Brainstorm Cell Therapeutics Inc.Weekly Profit Summary & Daily Chart Pattern Signals - Newser
Measuring Brainstorm Cell Therapeutics Inc.’s beta against major indicesJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - Newser
Automated trading signals detected on Brainstorm Cell Therapeutics Inc.Trade Analysis Report & Long-Term Safe Return Strategies - Newser
Can Brainstorm Cell Therapeutics Inc. stock outperform in a bear marketEarnings Trend Report & Real-Time Price Movement Reports - خودرو بانک
How to monitor Brainstorm Cell Therapeutics Inc. with trend dashboardsPortfolio Return Report & Weekly Breakout Stock Alerts - Newser
Published on: 2025-09-03 02:19:13 - Newser
Advanced analytics toolkit walkthrough for Brainstorm Cell Therapeutics Inc.Portfolio Update Summary & AI Based Buy and Sell Signals - Newser
Is it time to cut losses on Brainstorm Cell Therapeutics Inc.Weekly Trade Review & Fast Moving Stock Trade Plans - Newser
What is Brainstorm Cell Therapeutics Inc. s 5 year growth outlookMarket Performance Summary & Advanced Swing Trade Entry Plans - خودرو بانک
Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performanceQuarterly Market Summary & Daily Chart Pattern Signal Reports - Newser
Dip Buying: What is Brainstorm Cell Therapeutics Inc. s 5 year growth outlook2025 Market Sentiment & Technical Entry and Exit Alerts - خودرو بانک
Can Brainstorm Cell Therapeutics Inc. Escape Recent Bear Channel getLinesFromResByArray error: size == 0 - 강소기업뉴스
Brainstorm Cell Therapeutics Inc. Recovery Potential Based on Technical Tools getLinesFromResByArray error: size == 0 - news-j.co.kr
Is Brainstorm Cell Therapeutics Inc. forming higher highs and higher lows2025 Geopolitical Influence & Weekly Setup with High ROI Potential - خودرو بانک
Brainstorm Cell Therapeutics Inc. stock volume spike explainedJuly 2025 Short Interest & Technical Entry and Exit Tips - Newser
Brainstorm Cell Therapeutics Inc Stock (BCLI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.09%
Cap:
|
Volume (24h):